Use of high-purity forsythin in preparing bacteriostasis, antivirus medicine
A technology of forsythiaside and forsythiaside monomer, which is applied in the direction of antiviral agents, antibacterial drugs, and drug combinations, and can solve the research on antibacterial, antiviral, antipyretic and anti-inflammatory pharmacological activities of forsythiaside and other problems, to achieve good antibacterial and antiviral effects, inhibit proliferation, and improve immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0013] Embodiment 1 (antipyretic, anti-inflammatory)
[0014] 1.1 Purpose of the experiment
[0015] Observe the use of high-purity forsythiaside in antipyretic and anti-inflammatory aspects.
[0016] 1.2 Experimental materials
[0017] 1.2.1 Drugs
[0018] Test drug: high-purity forsythiaside: the active ingredient extract of forsythia; purity > 90%; provided by Shanghai Yusen New Drug Development Co., Ltd. Physical and chemical properties: This product is yellow powder. Storage conditions: 4°C, protected from light. Batch number: 060425.
[0019] Three dose groups (hereinafter referred to as high-purity groups) were set up in the test. ① Rat administration preparation method: according to 10ml / (kg d) tail vein injection administration, the low, middle and high dose groups are respectively equivalent to 3, 6, 12 times of clinical daily dosage; ② Mice administration preparation method : Administered at 10ml / (kg·d), the low, middle and high dose groups are respectively e...
Embodiment 2
[0063] Embodiment 2 (enhancing immunity test)
[0064] 2.1 Purpose of the experiment
[0065] Observe the use of high-purity forsythiaside in enhancing immunity.
[0066] 2.2 Experimental materials
[0067] With 1.2 experimental material in embodiment 1
[0068] 2.3 Data processing
[0069] Same as 1.3.
[0070] 2.4 Methods and Results
[0071] 2.4.1 Effect of high-purity forsythiaside on the carbon clearance ability of mice
[0072] The grouping was the same as in 1.4.1. Continuous tail vein injection of 10ml / kg was administered for 1 week. The mice in each group were injected with 0.1ml of 20% India ink through the tail vein respectively, and 20ul of blood was collected at 1 minute and 5 minutes after the injection and placed in 2ml0. Mix in 1% Na2CO3 solution, measure the OD value at 680nm, and calculate the K value according to the following formula.
[0073] Formula: K=(logOD1-logOD5) / (t5-t1)
[0074] The results showed that there was a significant difference betw...
Embodiment 3
[0087] Embodiment 3 (in vitro antiviral test)
[0088] 3.1 Virus multiplication:
[0089] Inoculate influenza type A on MDCK cells, add maintenance solution and culture at 37°C, 5% CO2, more than 90% of the lesions appear after 96 hours, freeze and thaw 3 times, blow and centrifuge, quantitatively aliquot, and store in -80°C refrigerator for later use .
[0090] 3.2 Determination of virus virulence:
[0091] Make a 10-fold serial dilution of the spare influenza A virus with the maintenance solution, repeat 3 wells vertically, inoculate horizontally on the monolayer cells in a 96-well plate, culture at 37°C, 5% CO2, observe the lesions every day, 48 After -96h, suck and discard the liquid in the plate wells, add 100ul of 1% neutral red, place at 37°C for 2h, discard the dye solution, fully elute excess dye with washing solution, add 100ul of decolorizing solution, decolorize at room temperature for 10min, and use enzyme The standard instrument measures the OD value at a wave...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com